Enter your keyword

Insights

High-Deductible Health Plans May Now Waive Cost Share for Coronavirus Tests

High-Deductible Health Plans May Now Waive Cost Share for Coronavirus Tests

On March 11th, the Internal Revenue Service (IRS) announced that high-deductible health plans (HDHPs) can pay first dollar coverage for 2019 Novel Coronavirus (COVID-19)-related testing and treatment, without jeopardizing their status. The IRS is taking these steps due to the nature of this public health emergency, and to avoid administrative delays or financial disincentives that […]

What is Leveraged Trend?

Those in the stop loss market have heard the phrase “leveraged trend” when discussing renewal calculations with your stop loss carrier.  While few understand how this works, all have seen its’ significant impact on your clients’ stop loss renewals. What is leveraged trend?  How is it calculated?  And more importantly, what can you do to […]

Employers Begin Taking Steps to Combat the Coronavirus

It is estimated over 75,000 people worldwide have been infected with the coronavirus, with death figures approaching 2800 people. The fear of this potentially deadly virus has employers beginning to take steps to protect their employees.  Coronavirus (2019-nCoV) was first identified in Wuhan, Hubei Province, China. Coronaviruses are a large family of viruses that are common […]

FDA Approves First Medication for Treatment of Peanut Allergy

FDA Approves First Medication for Treatment of Peanut Allergy

On January 31st, 2020, the U.S. Food and Drug Administration (FDA) approved Palforzia to reduce the risk of allergic reactions, including anaphylaxis, that may occur with accidental exposure to peanuts. Peanut allergy is a condition in which the body’s immune system mistakenly identifies small amounts of peanut as harmful. When this occurs individuals may experience […]

New Proposed Rules would Significantly Increase Hospital/Insurer Price Transparency for Employers

The U.S. Department of Health and Human Services recently released two sets of regulations that would make health care costs publicly available.  These regulations could significantly shake up the health care space making it easier for employers to design health benefits to steer employees toward hospitals with high value services. The first regulation (found HERE) […]

New Treatment to Prevent Sickle Cell Crisis

New Treatment to Prevent Sickle Cell Crisis

On November 15, 2020, the U.S. Food and Drug Administration approved Adakveo®, a treatment to reduce the frequency of vaso-occlusive crisis (VOC) in patients with sickle cell disease. These severe events are unpredictable and can cause life-threatening complications. Sickle cell disease is an inherited blood disorder in which the red blood cells are abnormally shaped […]

Employers, Payers Begin to Base Drug Coverage on ICER’s Value-Based Price Benchmark

A recent article by the Wall Street Journal explores the Institute for Clinical and Economic Review (ICER), and how payers are beginning to use this organization’s model to make medication coverage decisions. ICER has no political ties, which allows it to provide an independent examination on the price of drugs. ICER uses a model which […]